BIOVERATIV INC Managers
| Managers | Title | Age | Since |
|---|---|---|---|
William Sibold
PSD | President | - | 18-03-07 |
Joann Nestor
SEC | Corporate Secretary | - | - |
| Corporate Officer/Principal | - | - | |
Timothy Harris
PRN | Corporate Officer/Principal | 74 | 17-01-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
William Sibold
PSD | President | - | 18-03-07 |
Philippe Sauvage
BRD | Director/Board Member | - | 18-03-07 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 108,223,644 | 107,993,510 ( 99.79 %) | 0 | 99.79 % |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. |
Pharmaceuticals: Major
|
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
